Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

842 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE.
Fiske HW, Ward C, Shah SA, Holubar SD, Al-Bawardy B, Barnes EL, Binion D, Bohm M, Brand M, Clarke K, Cohen BL, Cross RK, Dueker J, Engels M, Farraye FA, Fine S, Forster E, Gaidos J, Ginsburg P, Goyal A, Hanson J, Herfath H, Hull T, Kelly CR, Lazarev M, Levy LC, Melia J, Philpott J, Qazi T, Siegel CA, Watson A, Wexner SD, Williams ED, Regueiro M. Fiske HW, et al. Among authors: siegel ca. Crohns Colitis 360. 2024 Apr 11;6(2):otae022. doi: 10.1093/crocol/otae022. eCollection 2024 Apr. Crohns Colitis 360. 2024. PMID: 38720935 Free PMC article.
Systemic Lupus Erythematosus: A Review.
Siegel CH, Sammaritano LR. Siegel CH, et al. JAMA. 2024 May 7;331(17):1480-1491. doi: 10.1001/jama.2024.2315. JAMA. 2024. PMID: 38587826 Review.
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Sands BE, D'Haens G, Clemow DB, Irving PM, Johns JT, Hunter Gibble T, Abreu MT, Lee S, Hisamatsu T, Kobayashi T, Dubinsky MC, Vermeire S, Siegel CA, Peyrin-Biroulet L, Moses RE, Milata J, Arora V, Panaccione R, Dignass A. Sands BE, et al. Among authors: siegel ca. Inflamm Bowel Dis. 2024 Mar 9:izae024. doi: 10.1093/ibd/izae024. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38459910
The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease.
Swaminathan A, Fulforth JM, Frampton CM, Borichevsky GM, Mules TC, Kilpatrick K, Choukour M, Fields P, Ramkissoon R, Helms E, Hanauer SB, Leong RW, Peyrin-Biroulet L, Siegel CA, Gearry RB. Swaminathan A, et al. Among authors: siegel ca. Inflamm Bowel Dis. 2023 Dec 22:izad294. doi: 10.1093/ibd/izad294. Online ahead of print. Inflamm Bowel Dis. 2023. PMID: 38134391
Outcomes and endpoints of postoperative recurrence in Crohn's Disease: systematic review and consensus conference.
Hammoudi N, Sachar D, D'Haens G, Reinisch W, Kotze PG, Vermeire S, Schölmerich J, Kamm MA, Griffiths A, Panes J, Ghosh S, Siegel CA, Bemelman W, O'Morain C, Steinwurz F, Fleshner P, Mantzaris GJ, Sands B, Abreu MT, Dotan I, Turner D, Dignass A, Allez M; International Organization for the Study of Inflammatory Bowel Diseases (IOIBD).. Hammoudi N, et al. Among authors: siegel ca. J Crohns Colitis. 2023 Dec 19:jjad205. doi: 10.1093/ecco-jcc/jjad205. Online ahead of print. J Crohns Colitis. 2023. PMID: 38112601
842 results